> Pharma’s most underestimated cyber risk isn’t a breach

Chirag Shah, Global Information Security Officer & DPO at Model N examines how cyber risk in pharma and life sciences is shifting beyond traditional breaches toward data misuse, AI-driven exposure and regulatory pressure. He explains why executives still underestimate silent control failures, how ransomware groups are weaponizing compliance risk, and why proof of security will increasingly require real-time governance, not audits, as cybersecurity and compliance continue to converge. By 2026, what category of cyber risk … More → The post Pharma’s most underestimated cyber risk isn’t a breach appeared first on Help Net Security.